7-[(1R,2S,3R,5S)-3,5-dihydroxy-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dienyl] cyclopentyl]-6-oxo-heptanoic acid
- $105 - $816
- Product name: 7-[(1R,2S,3R,5S)-3,5-dihydroxy-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dienyl] cyclopentyl]-6-oxo-heptanoic acid
- CAS: 68324-95-8
- MF: C20H32O6
- MW: 368.46
- EINECS:
- MDL Number:
- Synonyms:7-[(1R,2S,3R,5S)-3,5-dihydroxy-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dienyl] cyclopentyl]-6-oxo-heptanoic acid;Δ17-6-keto Prostaglandin F1α;HFKNJQYMAGMXTR-CAPHXMBKSA-N;Prosta-13,17-dien-1-oic acid, 9,11,15-trihydroxy-6-oxo-, (9α,11α,13E,15S,17Z)-;Δ17-6-keto Prostaglandin F1α;D17-6KPGF1A;17-6-keto Prostaglandin F1α
3 prices
Selected condition:
Brand
- Cayman Chemical
Package
- 100μg
- 500μg
- 1mg
- ManufacturerCayman Chemical
- Product number15230
- Product descriptionΔ17-6-keto Prostaglandin F1α ≥98%
- Packaging100μg
- Price$105
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number15230
- Product descriptionΔ17-6-keto Prostaglandin F1α ≥98%
- Packaging500μg
- Price$459
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number15230
- Product descriptionΔ17-6-keto Prostaglandin F1α ≥98%
- Packaging1mg
- Price$816
- Updated2024-03-01
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Cayman Chemical | 15230 | Δ17-6-keto Prostaglandin F1α ≥98% | 100μg | $105 | 2024-03-01 | Buy |
Cayman Chemical | 15230 | Δ17-6-keto Prostaglandin F1α ≥98% | 500μg | $459 | 2024-03-01 | Buy |
Cayman Chemical | 15230 | Δ17-6-keto Prostaglandin F1α ≥98% | 1mg | $816 | 2024-03-01 | Buy |
Properties
solubility :DMF: >50 mg/ml (from PGF1a); DMSO: >50 mg/ml (from PGF1a); Ethanol: >75 mg/ml (from PGF1a); PBS pH 7.2: >2.1 mg/ml (from PGF1a)
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | ||||||||||||||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||||||||||||||
Precautionary statements: |
|